Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants.

Oncotarget · 2017 · PMC5522308 · PMID 28418881

Europe PMC DOI

hedged sentences

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

borderline significantP = 0.051so close (0.05 < p ≤ 0.1)

With a random effects model, a borderline significant inverse association was observed between overall aspirin use and breast cancer risk, with a summarized RR = 0.94 ( P = 0.051, 95% CI 0.87-1.01).

also in 11,409 other papers

marginally statistically significantno p-value reported

Zhao YS [ 7 ] found that aspirin intake is related to a slight decrease in the development of breast cancer with a marginally statistically significant difference.

also in 1,110 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.